Stephanie Jaalouk

Stephanie Jaalouk is a seasoned professional in the pharmaceutical and life sciences sectors, currently serving as Strategic Management Lead and Chief of Staff at Bayer since April 2021. In this role, Stephanie has successfully managed the launch preparation for cardiovascular brands, developed market access strategies for KERENDIA®, and led cross-functional projects to improve patient care in diabetes. Previous roles include consulting on pricing and market access strategies at BearingPoint and quality assurance in bioinks and tissue engineering at CELLINK. Stephanie's educational background includes a Doctor of Pharmacy and a Master's in Biomedical Engineering, complemented by extensive internships in biotechnologies and genetics.